| Mrs Susan Albertini White, NURSE PRACTITIONER | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-4589 | |
| Not Available |
| Full Name | Mrs Susan Albertini White |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033276555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1010018221 (Vermont) | Primary |
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer
The American Fertility Association (AFA) disagrees with the Food and Drug Administration's (FDA) sperm donation guidelines, which take effect on May 25, 2005.
PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.
Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.
AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which now provides treatment and services for more than 110,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, expressed frustration and disappointment at the news that data that seriously undermines a widely reported Thai HIV vaccine trial were not released publicly when other, more favorable data from the vaccine trial were publicly reported late last month.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Susan Albertini White, NURSE PRACTITIONER 104 Skunk Hollow Rd, Jericho, VT 05465-3033 Ph: (802) 899-5458 | Mrs Susan Albertini White, NURSE PRACTITIONER 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-4589 |
News Archive
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer
The American Fertility Association (AFA) disagrees with the Food and Drug Administration's (FDA) sperm donation guidelines, which take effect on May 25, 2005.
PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.
Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.
AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which now provides treatment and services for more than 110,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, expressed frustration and disappointment at the news that data that seriously undermines a widely reported Thai HIV vaccine trial were not released publicly when other, more favorable data from the vaccine trial were publicly reported late last month.
› Verified 3 days ago
Ms. Maureen Louise Dwyer, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Mcclure 5 Fletcherallen Healthcare, 111colchester Ave, Burlington, VT 05401 Phone: 802-847-2804 Fax: 802-847-2806 | |
Ms. Merja Cahoon, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2370 | |
Brooke Hopkins Ryba, MSN, RN, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Patricia Manion, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Flynn Ave, Burlington, VT 05401 Phone: 802-488-6200 Fax: 802-488-6919 | |
Erin Michelle Leighton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1205 North Ave, Burlington, VT 05408 Phone: 802-863-1313 | |
Kayleigh Martincic, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Burlington, VT 05401 Phone: 802-657-7000 |